Evidence map›Paper›PMID 36136646›Full record

ArticleTropical medicine and infectious disease2022

Efficacy of Fosfomycin against Planktonic and Biofilm-Associated MDR Uropathogenic

Haziel Eleazar Dzib-Baak, Andrés Humberto Uc-Cachón, Angel de Jesús Dzul-Beh, Rey Fernando Rosado-Manzano, Carlos Gracida-Osorno, Gloria María Molina-Salinas

Open access · goldAbstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. [Gram-negative bacteria of critical priority in ICU patients from a tertiary care hospital].Revista medica del Instituto Mexicano del Seguro Social · 2023
    Observational
  5. UropathogenicMicroorganisms · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Haziel Eleazar Dzib-BaakUnidad de Investigación Médica Yucatán, Instituto Mexicano del Seguro Social, Mérida 97150, Mexico.ORCID 0000-0002-4697-9707
Andrés Humberto Uc-CachónUnidad de Investigación Médica Yucatán, Instituto Mexicano del Seguro Social, Mérida 97150, Mexico.ORCID 0000-0003-3845-7930
Angel de Jesús Dzul-BehUnidad de Investigación Médica Yucatán, Instituto Mexicano del Seguro Social, Mérida 97150, Mexico.ORCID 0000-0002-4971-7833
Rey Fernando Rosado-ManzanoUnidad Médica de Alta Especialidad, Instituto Mexicano del Seguro Social, Mérida 97150, Mexico.
Carlos Gracida-OsornoHospital General Regional No. 1, Instituto Mexicano del Seguro Social, Mérida 97150, Mexico.
Gloria María Molina-SalinasUnidad de Investigación Médica Yucatán, Instituto Mexicano del Seguro Social, Mérida 97150, Mexico.ORCID 0000-0002-3961-6449
Mexican Social Security Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urinary tract infections (UTI) are a severe public health problem and are caused mainly by the uropathogenic

Indexed as

biofilmfosfomycinmultidrug-resistanturopathogenic Escherichia coli

Identifiers

PMID36136646
PMCPMC9505523
OpenAlexW4296019819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.